相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Residual β cell function and monogenic variants in long-duration type 1 diabetes patients
Marc Gregory Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes
Emily K. Sims et al.
DIABETES CARE (2019)
Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide
Charles Thivolet et al.
DIABETOLOGIA (2019)
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM
Sabine Zenz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Michael R. Rickels et al.
TRANSPLANTATION (2018)
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
Saba Sheikh et al.
DIABETES (2017)
Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes
Wei Hao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES
Devin W. Steenkamp et al.
ENDOCRINE PRACTICE (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
Abnormalities of the Exocrine Pancreas in Type 1 Diabetes
Martha Campbell-Thompson et al.
CURRENT DIABETES REPORTS (2015)
Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes
Michael R. Rickels et al.
DIABETES (2015)
Demonstration of an Intrinsic Relationship Between Endogenous C-Peptide Concentration and Determinants of Glycemic Control in Type 1 Diabetes Following Islet Transplantation
Augustin M. Brooks et al.
DIABETES CARE (2015)
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Asa K. Davis et al.
DIABETES CARE (2015)
Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures
Michael R. Rickels et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Arginine is preferred to glucagon for stimulation testing of β-cell function
R. Paul Robertson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
Assessment of β-Cell Mass and α- and β-Cell Survival and Function by Arginine Stimulation in Human Autologous Islet Recipients
R. Paul Robertson et al.
DIABETES (2014)
Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis
Jennifer Sherr et al.
DIABETES CARE (2014)
Characterization of residual β cell function in long-standing type 1 diabetes
Jennifer L. Sherr et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes
Meidjie Ang et al.
DIABETOLOGIA (2014)
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
Richard A. Oram et al.
DIABETOLOGIA (2014)
Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus
Ana Maria Arbelaez et al.
PEDIATRIC DIABETES (2014)
Residual β-Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents
Jesper S. Sorensen et al.
DIABETES CARE (2013)
Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes
Jennifer Sherr et al.
DIABETES CARE (2013)
Improvement in Insulin Sensitivity After Human Islet Transplantation for Type 1 Diabetes
Michael R. Rickels et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Early Loss of the Glucagon Response to Hypoglycemia En Adolescents With Type 1 Diabetes
Aris Siafarikas et al.
DIABETES CARE (2012)
Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay
Limei Wang et al.
DIABETES CARE (2012)
Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes
Bryan C. Bergman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
Ken T. Coppieters et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells
Jean-Claude Henquin
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)
R. C. Loopstra-Masters et al.
DIABETOLOGIA (2011)
Insulin Reciprocally Regulates Glucagon Secretion in Humans
Benjamin A. Cooperberg et al.
DIABETES (2010)
β-Cell Secretory Capacity and Demand in Recipients of Islet, Pancreas, and Kidney Transplants
Michael R. Rickels et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Acute insulin responses to glucose and arginine as predictors of β-cell secretory capacity in human islet transplantation
Michael R. Rickels et al.
TRANSPLANTATION (2007)
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis
A. E. Butler et al.
DIABETOLOGIA (2007)
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?
JJ Meier et al.
DIABETOLOGIA (2005)
The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes
E Bernroider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual β-cell secretion and metabolic control in type 1 diabetic subjects
F Cavalot et al.
DIABETES CARE (2004)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Improved β-cell function after standardized weight reduction in severely obese subjects
M Guldstrand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes
S Sjöberg et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Insulin resistance in type 1 diabetes
CJ Greenbaum
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Impaired β-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose
CJ Greenbaum et al.
DIABETES (2002)
分享论文
